News

Turmeric, a common spice, has been used in Eastern medicine for centuries. Studies are now examining the benefits of yellow ...
Roflumilast foam, 0.3%, proved to be a simplified treatment regimen with high efficacy for patients with scalp and body ...
Discover why your skin develops scaling patches, from common dry skin to medical conditions requiring treatment, plus ...
ORKA-001, targeting IL-23p19, Phase 1 trial dosing complete, with data expected in 3Q 2025 ORKA-001 Phase 2a initiation expected in 2H 2025, with efficacy readout expected in 2H 2026 that will provide ...
Salt water may help exfoliate facial skin and treat certain skin diseases. Learn the science behind what it does and does not ...
Improvements with GLP-1 RAs in psoriasis and other chronic skin diseases point to their increased use in dermatology and a ...
Icotrokinra demonstrated high rates of clearance in scalp and genital psoriasis after 16 weeks of treatment, according to ...
The primary endpoint was met, with 57% of subjects treated with the therapy achieving clear or almost clear skin.
Atopic dermatitis causes flaky, itchy, dry, and inflamed skin. It can look different on darker skin, making it harder to spot ...
Skin rashes often signal hidden health problems. Learn when these mysterious skin warnings need medical attention beyond home ...
Roflumilast foam, 0.3% (Zoryve) used once-daily significantly improved itch and other symptoms of plaque psoriasis of the scalp and body, the phase III ARRECTOR trial showed.